Kaye Scholer Company Profile

11:49 EDT 20th March 2018 | BioPortfolio



425 Park Avenue
New York
New York
United States of America


Phone: (212) 836-8000
Fax: (212) 836-8689

News Articles [6 Associated News Articles listed on BioPortfolio]

Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup

Ed Kaye never thought he’d run a biotech —until waking up one day in 2015 realizing not only that he could, but that Sarepta Therapeutics, where he was chief medical officer at the time, may f...

Arnold & Porter Adds Ex-Sen. Dodd, Eli Lilly Litigation Chief

It was a busy day on the hiring front for Arnold & Porter Kaye Scholer , which said Tuesday that it had added Christopher Dodd, the former U.S. senator from Connecticut, and Steve Benz, who was he...

Senate set to resume tax bill debate with health care components uncertain

The Senate will debate and may vote on the Republican tax reform proposal today, with several critical health care components still undefined, possibly affecting millions of people and billions of dol...

Vatican treasurer in Australian court for hearing on sex offence charges

By Sonali Paul and Byron Kaye MELBOURNE (Reuters) - Vatican treasurer Cardinal George Pell arrived in an Australian court on Monday for the start of a four-week pre-trial hearing on charges of histor...

Collective Health Expands Leadership and Advisory Board with Healthcare and HR Industry Leaders

Collective Health today announced the addition of three seasoned healthcare and HR leaders who will provide critical expertise around driving greater value and innovation i...

Stoke Therapeutics Announces $40 Million Series A Financing to Create Pioneering New Medicines that Restore Gene Expression in Severe Genetic Diseases

Edward M. Kaye, M.D., industry leader in rare disease drug development, named Chief Executive Officer Company leveraging groundbreaking work on RNA splicing from S...

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Ligaments of the Face: Past, Present, and Future.

The aim of this study is to search for the origin of the term "ligament' in the face, present its status, and suggest a principle to rectify the use of unclear terminology.The structure that connects ...

Successful management of living donor liver transplantation for biliary atresia with single ventricle physiology-from peri-transplant through total cavopulmonary connection: A case report.

Children with single ventricle physiology have complete mixing of the pulmonary and systemic circulations, requiring staged procedures to achieve a separation of these circulations, or Fontan circulat...

Clinical Trials [0 Results]


Companies [5 Associated Companies listed on BioPortfolio]

Kaye Scholer LLP

Kaye Scholer


Kaye/Bassman International Corp.

Company History | Welcome to Kaye/Bassman International Corp. (KBIC). Our organization was founded in 1981 with a mission of positively impacting companies and enhancing careers by providing the fines...

Partnership Fund for New York City

The Partnership Fund for New York City is the $115 million investment arm of the Partnership for New York City ( The Fund’s mission is to engage the City’...

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...

More Information about "Kaye Scholer" on BioPortfolio

We have published hundreds of Kaye Scholer news stories on BioPortfolio along with dozens of Kaye Scholer Clinical Trials and PubMed Articles about Kaye Scholer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kaye Scholer Companies in our database. You can also find out about relevant Kaye Scholer Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record